Novel lipid-lowering agents proprotein convertase subtilisin-kexin type 9 inhibitors: Do they show mortality benefits?
This is a temporary file and hence do not link it from a website, instead link the URL of this page if you wish to link the PDF file.
To read this article you will require Adobe© Acrobat Reader, if you do not have this installed you can download it from here
Support open access
Subscribe for print copies